Sponsored by:

ITM, Radiopharm ink Lu-177 supply agreement

AuntMinnie.com staff writers
May 20, 2025

ITM Isotope Technologies Munich SE (ITM) and Radiopharm Theranostics have entered into an agreement under which ITM will supply that company with non-carrier-added lutetium-177 (n.c.a. Lu-177) for Radiopharm Theranostics' radiopharmaceutical therapies pipeline.

Radiopharm Theranostics will use ITM's n.c.a. Lu-177 in its development of RAD 204 (PD-L1-targeting nanobody, phase I), RAD 202 (HER2-targeting nanobody, phase I), and RV01 (B7-H3-targeting monoclonal antibody, preclinical), for the treatment of solid tumors, according to the two firms.

Latest in Molecular Imaging
Representative F-18 FDG-PET/CT and Tc-99m FAPI-SPECT/CT scans for five study patients with gastrointestinal cancer. FDG-PET/CT and FAPI-SPECT/CT images show that uptake occurred in metastatic lymph nodes (LNs) (patient number 50, D) and bone metastases (patient number 33, C). FAPI-SPECT/CT outperformed FDG-PET/CT in detecting liver metastases (patient number 3, A; and 15,B) and peritoneal spread metastases (patient number 27, E). Red arrows indicate foci additionally found by FAPI-SPECT/CT.
FAPI-SPECT/CT shows promise diagnosing gastrointestinal cancer
May 19, 2025
Biograph PET/CT: Truly ready to address your imaging needs
Sponsored
Biograph PET/CT: Truly ready to address your imaging needs
May 2, 2025
AI models can generate synthetic equivalents to PET images from routinely acquired T1W MRI scans.
ISMRM: Barriers face synthetic amyloid PET image development
May 14, 2025
Representative stress perfusion CMR case with 80% contrast dose reduction. Pixel-wise MBF maps and AHA 16-segment bull's eye plots are shown for full-dose and reduced-dose acquisitions. When analyzed using the proposed MST deep learning method, the reduced-dose data closely matches the full-dose data across basal, mid, and apical slices. In contrast, Fermi-deconvolution shows good agreement in apical and mid slices but overestimates MBF in some basal segments, indicating reduced accuracy under low-dose conditions. Image courtesy of the ISMRM.
ISMRM: AI spots ischemic heart disease on low GBCA dose images
May 14, 2025
Related Stories
An axial CT image illustrating segmentation of functioning kidney tissue (blue areas), excluding kidney cysts and renal pelvis, using TotalSegmentator. Image and caption courtesy of RSNA.
CT
AI helps predict kidney function decline in Lu-177 patients
Kesner Zanzonico
Molecular Imaging
Dosimetry key in Lu-177 cancer therapy
Isotopes1
Nuclear Medicine
Shine and Primo Biotechnology ink Lu-177 supply deal
Biograph PET/CT: Truly ready to address your imaging needs
Sponsor Content
Biograph PET/CT: Truly ready to address your imaging needs
More in Molecular Imaging
FAPI-SPECT/CT shows promise diagnosing gastrointestinal cancer
By Will Morton
FAPI-SPECT/CT is comparable to FDG-PET/CT for detecting lesions in patients with gastrointestinal cancer, a study shows.
May 19, 2025
Representative F-18 FDG-PET/CT and Tc-99m FAPI-SPECT/CT scans for five study patients with gastrointestinal cancer. FDG-PET/CT and FAPI-SPECT/CT images show that uptake occurred in metastatic lymph nodes (LNs) (patient number 50, D) and bone metastases (patient number 33, C). FAPI-SPECT/CT outperformed FDG-PET/CT in detecting liver metastases (patient number 3, A; and 15,B) and peritoneal spread metastases (patient number 27, E). Red arrows indicate foci additionally found by FAPI-SPECT/CT.
Algernon to acquire NoBrainer Imaging Centers
By AuntMinnie.com staff writers
Algernon Pharmaceuticals has entered an agreement to acquire NoBrainer Imaging Centers.
May 14, 2025
A Dpatient
ISMRM: Barriers face synthetic amyloid PET image development
By Will Morton
Work on developing synthetic amyloid PET images from MRI scans is in its early stages.
May 14, 2025
AI models can generate synthetic equivalents to PET images from routinely acquired T1W MRI scans.
ISMRM: AI spots ischemic heart disease on low GBCA dose images
By Erik L. Ridley
An AI-based framework was highly accurate for detecting myocardial ischemia, even on images acquired with 90% less gadolinium.
May 14, 2025
Representative stress perfusion CMR case with 80% contrast dose reduction. Pixel-wise MBF maps and AHA 16-segment bull's eye plots are shown for full-dose and reduced-dose acquisitions. When analyzed using the proposed MST deep learning method, the reduced-dose data closely matches the full-dose data across basal, mid, and apical slices. In contrast, Fermi-deconvolution shows good agreement in apical and mid slices but overestimates MBF in some basal segments, indicating reduced accuracy under low-dose conditions. Image courtesy of the ISMRM.
ISMRM: Trimodal PET-MR-FUS may be feasible therapy monitoring option
By Amerigo Allegretto
Researchers at ISMRM 2025 touted the success of a trimodal MR-PET-FUS system that could have applications for therapy monitoring.
May 10, 2025
Researchers at ISMRM highlighted the success of a trimodal MR-PET-FUS system built around a low-field MRI scanner. MR (top) and PET (bottom) images were acquired simultaneously before and after FUS heating.
Beta-amyloid testing results have limited emotional impact for patients
By Maryam Payne
Receiving results from amyloid beta testing did not have a significant negative emotional impact on patients, whether negative or positive, findings from a new study show.
May 9, 2025
Brain Amyloid Plaque Neuron
PET/MRI reveals how brain stimulation technique works
By Will Morton
PET/MRI scans have revealed the mechanism underlying a brain stimulation technique for treating neurological and psychiatric conditions.
May 9, 2025
2025 05 09 Brain Stimulation Thumbnail
Whole-body PET shows how naloxone blocks opioids
By Will Morton
PET imaging has shown for the first time how the opioid overdose treatment naloxone blocks neuroreceptors throughout the body.
May 9, 2025
Naloxone2 Thumbnail
Shine to buy Lantheus’ SPECT business
By AuntMinnie.com staff writers
Medical isotope developer Shine Technologies has entered an agreement to acquire Lantheus Holdings’ SPECT business.
May 7, 2025
Acquisitions
Siemens posts strong revenue growth in Q2 2025
By AuntMinnie.com staff writers
Siemens Healthineers reported revenue growth in the second quarter of 2025 compared to last year.
May 7, 2025
Siemens2
SPECT/CT MPI may guide medical therapy in CAD patients
By Will Morton
SPECT/CT myocardial perfusion imaging can identify patients with coronary artery disease who are more likely to benefit from specific therapies.
May 7, 2025
Screenshot 2025 05 06 141932
FDA clears GE's new dual-head SPECT/CT system
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has cleared GE HealthCare's (GEHC) new dual-head SPECT/CT system, Aurora.
May 5, 2025
Gehc
Page 1 of 604
Next Page